Overexpression of miR-155 in the SOD1 mouse and both sporadic and familial human ALS. Targeting miR-155 in SOD1 mice restores dysfunctional microglia and ameliorates disease. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.